Broad Street Clinical Consulting helps plan and conduct every aspect of clinical research from protocol design to final results report and publication. Every breakthrough biotechnology is unique and poised to improve patient outcomes; the clinical studies evaluating the technology should be customized to highlight its capabilities while also serving the company's business needs. Broad Street understands the priorities for clinical research from First in Human Pilot Studies to Pivotal Regulatory Trials to Post-Market Surveillance. Designing and conducting strategic and efficient clinical trials results in a quick path to regulatory approval and a successful entry into the competitive global marketplace. Based in the Research Triangle Park area in North Carolina, Broad Street works with clients from coast to coast and in Europe; remote collaborations are as seamless as face-to-face. Clients include companies ranging from start-ups to Fortune 500 corporations. Therapeutic areas span cardiology, neurology, urology, oncology, pulmonology, infectious disease, obesity, and others. Technologies include imaging modalities, implants, therapeutic catheters, hemostatic agents, and more.